IMMUPHARMA (IMM)

 

Latest News

ImmuPharma chairman dies

ImmuPharma has announced that chairman and co-founder Richard Warr died last last week. Chief executive Dimitri D...

Richard Warr

RNS Number: 3521U Immupharma PLC 29 July 2015 FOR IMMEDIATE RELEASE 29 JULY 2015 RICHARD WARR ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), the specialist drug discovery and development company is truly saddened to announce that Richard Warr, Chairman, passed away late last week. Dimitri Dimitrou, Chief Exec...

ImmuPharma clinical trials of Lupuzor 'live'

ImmuPharma has announced that registration with the US National Institutes of Health - ClincialTrials.gov website has no...

TERM SHEET SIGNED $14 MILLION FUNDING FOR LUPUZOR

RNS Number: 0955U Immupharma PLC 27 July 2015 27 JULY 2015 IMMUPHARMA PLC CLINICALTRIALS.GOV REGISTRATION OF LUPUZOR PIVOTAL PHASE III TRIAL TERM SHEET SIGNED WITH US INVESTOR TO SECURE UP TO $14 MILLION FUNDING FOR LUPUZOR ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), ...

All News

DateHeadlineSource
29-07-15ImmuPharma chairman dies StockMarketWire
29-07-15Richard WarrRNS
27-07-15ImmuPharma clinical trials of Lupuzor 'live' StockMarketWire
27-07-15TERM SHEET SIGNED $14 MILLION FUNDING FOR LUPUZORRNS
25-06-15Lupuzor founder awarded 'CNRS Medal of Innovation'StockMarketWire
25-06-15Lupuzor's Founder Dr Slyviane Muller Awarded MedalRNS
29-05-15ImmuPharma resolutions passed at AGMStockMarketWire
29-05-15Result of AGMRNS
06-05-15Annual Report & AccountsRNS
06-05-15ImmuPharma appoints interim chairman StockMarketWire
06-05-15Interim Board ChangeRNS
30-04-15ImmuPharma losses narrow StockMarketWire
30-04-15Directorate ChangeRNS
30-04-15Preliminary ResultsRNS
11-02-15Immupharma completes clinical trial StockMarketWire
11-02-15CANCER UPDATE: IPP-204106RNS
27-01-15ImmuPharma gets assurance over EIS StockMarketWire
27-01-15Enterprise Investment Scheme StatusRNS
22-01-15FTSE surges as ECB unveils QE, financials riseStockMarketWire
22-01-15FTSE cautiously up as ECB's QE call nearsStockMarketWire
22-01-15Collaboration Agreement with Simbec-OrionRNS
30-10-14Holding(s) in CompanyRNS
28-10-14Holding(s) in CompanyRNS
21-10-14FTSE 100 makes strong recoveryStockMarketWire
21-10-14FTSE 100 bounces backStockMarketWire
21-10-14ImmuPharma raises £3.4m StockMarketWire
21-10-14Additional Listing - Conditional PlacingRNS
20-10-14ImmuPharma unit awarded €400,000 grant StockMarketWire
20-10-14ImmuPharma awarded EUR400,000 GrantRNS
30-09-14Losses remain at ImmuPharmaStockMarketWire
30-09-14Half Yearly ReportRNS
30-09-14LupuzorT Gears Up To Start Pivotal Phase III trialRNS
27-06-14Immupharma shareholders approve AGM resolutionsStockMarketWire
27-06-14Result of AGMRNS
27-06-14ImmuPharma extends research capabilitiesStockMarketWire
27-06-14Access to pioneering research in Bordeaux FranceRNS
16-06-14ImmuPharma granted new Nucant patents StockMarketWire
16-06-14NEW NUCANT PATENTSRNS
23-05-14Annual Financial ReportRNS
21-05-14ImmuPharma pre-tax losses riseStockMarketWire

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory